Chemistry: molecular biology and microbiology – Measuring or testing process involving enzymes or... – Involving antigen-antibody binding – specific binding protein...
Reexamination Certificate
2005-12-06
2005-12-06
Achutamurthy, Ponnathapu (Department: 1652)
Chemistry: molecular biology and microbiology
Measuring or testing process involving enzymes or...
Involving antigen-antibody binding, specific binding protein...
C435S006120, C530S350000, C530S399000, C536S023100
Reexamination Certificate
active
06972178
ABSTRACT:
Assays are presented for screening for chemicals which affect the binding between proteins comprising an SH3 binding motif and nuclear receptor proteins. PNRC (Proline-rich Nuclear Receptor Co-regulatory protein) is a co-regulatory protein comprising an SH3 binding motif and was identified using bovine SF1 as the bait in a yeast two-hybrid screening of a human mammary gland cDNA expression library. This nuclear receptor coactivator binds to several nuclear receptors including those which regulate the aromatase gene which is involved in breast cancer. Compounds which affect the binding of PNRC to nuclear receptors can affect the expression of the aromatase gene as well as of other genes whose expression is under the control of nuclear receptors to which PNRC binds. PNRC is unique in that it has a molecular weight of 35 kDa, significantly smaller than most of the co-regulatory proteins reported so far, and it is proline-rich. In yeast two-hybrid assays, PNRC interacted with the orphan receptors SF1 and ERRα1 in a ligand-independent manner. PNRC was also found to interact with the ligand-binding domains (LBDs) of all the nuclear receptors tested including ER, AR, PR, TR, RAR, and RXR in a ligand-dependent manner. A 23-amino acid region, aa 278-300, in the carboxy-terminal region was shown to be critical and sufficient for the interaction with nuclear receptors. This region is proline-rich and contains an SH3-binding motif, S-D-P-P-S-P-S (SEQ ID NO:5).
REFERENCES:
Chen et al. Cloning a cDNA from human Nk/T cells which codes for a protein with high proline content. Biochemical et Biophysica Acta. 1995, vol. 1264, pp. 19-22.
Agarwal, V.R. et al. “Use of Alternative Promoters to Express the Aromatase Cytochrome P450 (CYP19) Gene in Breast Adipose Tissues of Cancer-Free and Breast Cancer Patients”,J. Clin. Endocrinol. Metab., 1996; 81:3843-3849.
Bingle, C.D. “Generation of a Rat Bronchiolar Epithelial Cell cDNA Library: Isolation of a Proline Rich Protein Highly Enriched in Bronchiolar Epithelial Cells”,Biochemical and Biophysical Research Communications, 1996; 225:877-882.
Boulikas, T. “Nuclear Locailization Signals (NLS)”,Critical Reviews in Eukaryotic Gene Expression, 1993; 3(3): 193-227.
Cavaillés, V. et al. “Interaction of proteins with transcriptionally active estrogen receptors”,Proc. Natl. Acad. Sci. USA, Oct. 1994; 91:10009-10013.
Cavaillés, V. et al. “Nuclear factor RIP 140 modulates transcriptional activation by the estrogen receptor”,The EMBO Journal, 1995; 14(15):3741-3751.
Chakravarti, D. et al. “Role of CBP/P300 in nuclear receptor signalling”,Nature, Sep. 5, 1996; 383:99-103.
Chen, J. et al. “Cloning a cDNA from human NK/T cells which codes for a protein with high proline content”,Biochimica et Biophysica Acta, 1995; 1264:19-22.
Ding, X.F. et al. “Nuclear Receptor-Binding Sites of Coactivators Glucocorticoid Receptor Interacting Protein 1 (GRIP1) and Steroid Receptor Coactivator 1 (SRC-1): Multiple Motifs with Different Binding Specificities”,Molecular Endocrinology, 1998; 12:302-313.
Feng, S. et al. “Two Binding Orientations for Peptides to the Src SH3 Domain: Development of a General Model for SH3-Ligand Interactions”,Science, Nov. 18, 1994; 266:1241-1247.
Glass, C.K. et al. “Nuclear receptor coactivators”,Current Opinion in Cell Biology, 1997; 9:222-232.
Halachmi, S. et al. “Estrogen Receptor-Associated Proteins: Possible Mediators of Hormone-Induced Transcription”,Science, Jun. 3, 1994; 264:1455-1458.
Hanstein, B. et al. “p300 is a component of an estrogen receptor coativator complex”,Proc. Natl. Acad. Sci. USA, Oct. 1996; 93:11540-11545.
Harada, N. “Aberrant Expression of Aromatase in Breast Cancer Tissues”,J. Steroid Biochem. Molec. Biol., 1997; 61(3-6):175-184.
Heery, D.M. et al. “A signature motif in transcriptional co-activators mediates binding to nuclear receptors”,Nature, Jun. 12, 1997; 387:733-736.
Hong, H. et al. “GRIP1, a novel mouse protein that serves as a transcriptional coactivator in yeast for the hormone binding domains of steroid receptors”,Proc. Natl. Acad. Sci. USA, May 1996; 93:4948-4952.
Horwitz, K.B. et al. “Nuclear Receptor Coactivators and Corepressors”,Molecular Endocrinology, 1996; 10:1167-1177.
Kamei, Y. et al. “A CBP Integrator Complex Mediates Transcriptional Activation and AP-1 Inhibition by Nuclear Receptors”,Cell, May 3, 1996; 85:403-414.
Le Douarin, B. et al. “The N-terminal part of TIF1, a putative mediator of the ligand-dependent activation function (AF-2) of nuclear receptors, is fused to B-raf in the oncogenic protein T18”,The EMBO Journal, 1995; 14(9):2020-2033.
Lee, J.W. et al. “Interaction of thyroid-hormone receptor with a conserved transcriptional mediator”,Nature, Mar. 2, 1995; 374:91-94.
Onate, S.A. et al. “Sequence and Characterization of a Coactivator for the Steroid Hormone Receptor Superfamily”,Science, Nov. 24, 1995; 270:1354-1357.
Pawson; T. “Protein modules and signalling networks”,Nature, Feb. 16, 1995; 373:573-580.
Shibata, H. et al. “Role of Co-activators and Co-repressors in the Mechanism of Steroid/Thyroid Receptor Action”,Recent Progress in Hormone Research, 1997; 52:141-165.
Suzuki, M. “SPXX, a Frequence Sequence Motif in Gene Regulatory Proteins”,J. Mol. Biol., 1989; 207:61-84.
Treuter, E. et al. “A Regulatory Role for RIP140 in Nuclear Receptor Activation”,Molecular Endocrinology, 1998; 12:864-881.
Voegel, J.J. et al. “TIF2, a 160 kDa transcriptional mediator for the ligand-dependent activation function AF-2 of nuclear receptors”,The EMBO Journal, 1996; 15(14):3667-3675.
vom Baur, E. et al. “Differential ligand-dependent interactions between the AF-2 activating domain of nuclear receptors and the putative transcriptional intermediary factors mSUG1 and TIF1”,The EMBO Journal, 1996; 15(1):110-124.
Wang, J. et al. “Indentification of a Promoter and a Silencer at the 3′-End of the First Intron of the Human Aromatase Gene”,Molecular Endocrinology, 1992; 6:1479-1488.
Williamson, M.P. “The structure and function of proline-rich regions in proteins”,Biochem. J., 1994; 297:249-260.
Yang, C. et al. “Modulation of Aromatase Expression in the Breast Tissue by ERRα-1 Orphan Receptor”,Cancer Research; Dec. 15, 1998; 58:5695-5700.
Zhou, C. et al. “Aromatase Gene Expression and its Exon I Usage in Human Breast Tumors. Detection of Aromatase Messenger RNA by Reverse Transcription-polymerase Chain Reaction”,J. Steroid Biochem. Molec. Biol., 1996; 59(2):163-171.
Zhou, D. et al. “Characterization of Silencer Element in the Human Aromatase Gene”,Archives of Biochemistry and Biophysics, May 15, 1998; 353(2):213-220.
Zhou, D. et al. “Identification and Characterization of a cAMP-Responsive Element in the Region Upstream from Promoter 1.3 of the Human Aromatase Gene”,Archives of Biochemistry and Biophysics, Nov. 15, 1999; 371(2):179-190.
Zhou, D. et al. “Identification of a Promoter That Controls Aromatase Expression in Human Breast Cancer and Adipose Stromal Cells”,The Journal of Biological Chemistry, Jun. 21, 1996; 271(25):15194-15202.
Jordan, V.C., “Targeted Antiestrogens to Prevent Breast Cancer,”Trends Endocrinol. Metab, 10(8):312-317, Oct. 1999.
Bentrem, D.J. et al., “Targeted Antiestrogens for the Prevention of Breast Cancer.”Oncol. Res., 11(9):401-7, 1999.
Levenson, A.S., “Selective Oestrogen Receptor Modulator: Molecular Pharmacology for the Millennium,”Eur. J. Cancer, 35(14):1974-85, Dec. 1999.
Chen Shiuan
Zhou Dujin
Achutamurthy Ponnathapu
City of Hope
Fronda Christian L.
Rothwell Figg Ernst & Manbeck
LandOfFree
Drug screening using a proline-rich nuclear receptor... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Drug screening using a proline-rich nuclear receptor..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Drug screening using a proline-rich nuclear receptor... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3492259